Loading clinical trials...

Gut Microbiota Metagenomics for Chronic Liver Disease | Clinical Trials | Clareo Health

UNKNOWN

Gut Microbiota Metagenomics for Chronic Liver Disease

Research Based on Gut Microbiota Metagenomics for Prevention of Chronic Liver Disease

NCT04339725•Chuncheon Sacred Heart Hospital

View on ClinicalTrials.gov

Summary

Gut microbiota modulation has effect on chronic liver disease

Detailed Description

Chronic liver disease has been known as a disease of the liver which lasts over a period of 6-month. It consists of inflammation, hepatitis, cirrhosis, hepatocellular carcinoma. Gut microbiota plays an important roles in the chronic liver disease. It can suppress the progression of the liver disease by moulation gut microbiota. The investigators are still evaluating the effect of gut microbiota on the liver disease.

Eligibility

Age

31 - 82 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Age 19+
•Normal : AST or ALT level \< 50IU/L, BMI \< 25
•Liver disease : AST or ATL level ≥ 50IU/L, BMI ≥ 25
•Patients hospitalized with chronic liver disease (viral hepatitis, alcoholic liver disease, non-alcoholic liver disease, cirrhosis, liver cancer)

Exclusion Criteria

•Normal : AST or ATL level ≥ 50IU/L, BMI ≥ 25
•Liver disease : AST or ALT level \< 50IU/L, BMI \< 25
•If the patient refuses

Locations (1)

Department of Internal Medicine, Hallym University Chuncheon Sacred Heart Hospital

Chuncheon, South Korea

Key Dates

Start Date

April 1, 2017

Primary Completion Date

March 1, 2020

Completion Date

January 1, 2025

Last Updated

April 9, 2020

Enrollment

3,240

ACTUAL participants

Conditions

Liver Disease Chronic

Interventions

DNA extraction

OTHER

A Phase Ib Clinical Study for rhTPO in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease

NCT05193201

Liver Disease ChronicThrombocytopenia

View study

COMPLETEDNA

Inspiratory Muscle Training Post-Liver Transplant

NCT03130608

Liver Disease ChronicMuscle Weakness+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 9, 2020Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions